🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Fast + Empagliflozin

Found 30 matching trials

Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated Tablets

PHASE1

An open label, balanced, randomized, single dose, two treatment, two sequen...

Status

Completed

Location

Veeda Clinical Research Ltd.

Start Date

2024-12-23

Trial ID

NCT06932159

Treatments Being Tested

Empagliflozin + Linagliptin film-coated tablets Glyxambi film-coated tablets

A Bioequivalence Study of Two Formulations of 10-mg Empagliflozin Tablets in Healthy Thai Volunteers Under Fasting Conditions

PHASE1

Objectives: Primary: to evaluate the bioequivalence of two formulations o...

Status

Unknown

Location

Multiple Locations

Start Date

2024-05-28

Trial ID

NCT06308679

Treatments Being Tested

Empagliflozin 10 mg tablets JARDIANCE®

Bioequivalence Study of Empagliflozin 25 mg Film-coated Tablets in Healthy Thai Volunteers

PHASE1

To determine and compare the rate and extent of absorption of a test formul...

Status

Unknown

Location

Multiple Locations

Start Date

2024-07-01

Trial ID

NCT06337409

Treatments Being Tested

Generic empagliflozin 25 mg film-coated tablets

Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions.

PHASE1

Investigation of food effect on the bioavailability of a 25 mg empagliflozi...

Status

Completed

Location

1245.79.1 Boehringer Ingelheim Investigational Site

Start Date

2011-10

Trial ID

NCT01451775

Treatments Being Tested

Empagliflozin Empagliflozin Empagliflozin

Effects of Glucose Lowering Agents in South Asian Women With Impaired Glucose Tolerance or Impaired Fasting Glucose

PHASE2

This study will test the effect of four common oral anti-diabetic agents on...

Status

Unknown

Location

Oslo University Hospital, Aker Hospital

Start Date

2021-02-10

Trial ID

NCT04662866

Treatments Being Tested

Metformin capsule 500 mg, Empagliflozin encapsulated tablet 10 mg, Pioglitazone encapsulated tablet 30 mg, Linagliptin encapsulated tablet 5 mg

To Compare and Evaluate the Oral Bioavailability of Empagliflozin + Linagliptin 10 mg/5 mg Filmcoated Tablets With That of Glyxambi 10 mg/ 5 mg Film-coated Tablets in Healthy, Adult, Human Subjects Under Fasting Conditions.

PHASE1

To compare and evaluate the oral bioavailability of Empagliflozin + Linagli...

Status

Completed

Location

Veeda Clinical Research Ltd.

Start Date

2025-03-08

Trial ID

NCT07039890

Treatments Being Tested

Empagliflozin + Linagliptin filmcoated tablets Glyxambi film-coated tablets

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component(Empagliflozin and Metformin) in Healthy Adult Volunteers in Fast Condition.

PHASE1

This study is to compare and evaluate the safety and pharmacokinetic charac...

Status

Completed

Location

Chungbuk National University Hospital

Start Date

2023-02-24

Trial ID

NCT05823870

Treatments Being Tested

DW6014

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets

PHASE1

To investigate safety, tolerability, pharmacokinetics and pharmacodynamics ...

Status

Completed

Location

1245.2.1 Boehringer Ingelheim Investigational Site

Start Date

2007-07

Trial ID

NCT01924767

Treatments Being Tested

BI 10773 Placebo BI 10773 BI 10773 Placebo BI 10773 BI 10773 Placebo BI 10773 Placebo BI 10773 BI 10773

Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction

PHASE4

Research hypothesis: Fast telemonitored medical sequencing in patients wit...

Status

Active Not Recruiting

Location

Sahlgrenska University Hospital

Start Date

2022-10-22

Trial ID

NCT05637853

Treatments Being Tested

GDMT

Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability

PHASE1

The objective of the current study is to determine the relative bioavailabi...

Status

Completed

Location

1276.5.1 Boehringer Ingelheim Investigational Site

Start Date

2010-10

Trial ID

NCT01211197

Treatments Being Tested

C: BI 10773 / metformin tablet B: BI 10773 tablet and metformin tablet A: BI 10773 / metformin tablet

Previous Next